PIN90 Discrete Choice Experiments (DCES) in HIV/AIDS Treatment: Expert Judgement in Comparison to Patient Preferences
نویسندگان
چکیده
منابع مشابه
Using discrete choice experiments to define patient preferences for outcomes in trials
Methods Web-based survey, containing discrete choice experiments (DCEs) to elicit preferences of three pre-defined groups of adults with epilepsy (n=750): (i) early epilepsy, (ii) established epilepsy, (iii) women of childbearing age (WOCBA). The DCEs contains five attributes, with two levels, defined using: semi-structured interviews with patients (n=56), a focus group with AED prescribers (n=...
متن کاملUse of discrete choice experiments to elicit preferences.
This paper considers the application of discrete choice experiments for eliciting preferences in the delivery of health care. Drawing upon the results from a recently completed systematic review, the paper summarises the application of this technique in health care. It then presents a case study applying the technique to rheumatology outpatient clinics. 200 patients were questioned about the im...
متن کاملEliciting Preferences for Health Insurance in Iran Using Discrete Choice Experiment Analysis
Background The preferences of Iranians concerning the attributes of health insurance benefit packages are not well studied. This study aimed to elicit health insurance preferences among insured people in Iran during 2016. Methods A mixed method...
متن کاملRanking in discrete choice experiments
A common problem in ethology is ranking of animal preferences for several discrete stimuli or options. We considered experiments where animals chose one of all possible simultaneously presented options. The animals might be observed at repeated occasions. In the ethological literature the analysis is often focused on testing the global hypotheses of no difference in preferences by non-parametri...
متن کاملExamining patient preferences in the treatment of rheumatoid arthritis using a discrete-choice approach
BACKGROUND Biological disease-modifying antirheumatic drugs (bDMARDs) used in second-line treatment of rheumatoid arthritis (RA) are administered parenterally. However, so-called targeted synthetic DMARDs (tsDMARDs) - developed more recently - offer alternative (ie, oral) administration forms in second-line treatment. Since bDMARDs and tsDMARDs can be regarded as equal in terms of efficacy, the...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Value in Health
سال: 2011
ISSN: 1098-3015
DOI: 10.1016/j.jval.2011.08.276